Cigna Corporation (NYSE:CI) EVP Lisa R. Bacus sold 2,236 shares of the business’s stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $179.95, for a total transaction of $402,368.20. Following the sale, the executive vice president now owns 18,501 shares of the company’s stock, valued at $3,329,254.95. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Shares of Cigna Corporation (NYSE:CI) traded down 1.02% during mid-day trading on Thursday, hitting $178.03. 1,065,839 shares of the stock traded hands. The company has a market cap of $44.82 billion, a P/E ratio of 20.54 and a beta of 0.46. Cigna Corporation has a 12 month low of $115.03 and a 12 month high of $181.00. The firm has a 50 day moving average of $173.09 and a 200 day moving average of $159.93.

Cigna Corporation (NYSE:CI) last posted its quarterly earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share for the quarter, topping analysts’ consensus estimates of $2.48 by $0.43. The firm had revenue of $10.32 billion for the quarter, compared to analyst estimates of $10.26 billion. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. Cigna Corporation’s quarterly revenue was up 3.6% on a year-over-year basis. During the same period in the previous year, the business posted $1.98 earnings per share. Equities analysts anticipate that Cigna Corporation will post $10.03 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Insider Selling: Cigna Corporation (CI) EVP Sells 2,236 Shares of Stock” was posted by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at https://www.americanbankingnews.com/2017/08/17/insider-selling-cigna-corporation-ci-evp-sells-2236-shares-of-stock.html.

A number of equities research analysts have weighed in on CI shares. Deutsche Bank AG boosted their target price on shares of Cigna Corporation from $180.00 to $190.00 and gave the company a “buy” rating in a research note on Monday, August 7th. Morgan Stanley upped their price objective on Cigna Corporation from $184.00 to $188.00 and gave the stock an “overweight” rating in a research note on Monday, August 7th. CIBC upped their price objective on Cigna Corporation from $174.00 to $185.00 and gave the stock an “outperform” rating in a research note on Thursday, June 15th. Wells Fargo & Company restated a “market perform” rating and issued a $174.00 price objective (up from $163.00) on shares of Cigna Corporation in a research note on Monday, June 19th. Finally, Oppenheimer Holdings, Inc. upped their price objective on Cigna Corporation from $174.00 to $185.00 and gave the stock an “outperform” rating in a research note on Thursday, June 15th. Three investment analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company’s stock. Cigna Corporation currently has a consensus rating of “Buy” and an average target price of $180.44.

A number of institutional investors have recently bought and sold shares of the company. Guardian Life Insurance Co. of America raised its position in Cigna Corporation by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock valued at $145,000 after buying an additional 7 shares during the last quarter. Private Trust Co. NA purchased a new position in Cigna Corporation during the first quarter valued at $205,000. Asset Advisors Corp raised its position in Cigna Corporation by 7.3% in the first quarter. Asset Advisors Corp now owns 29,845 shares of the health services provider’s stock valued at $4,372,000 after buying an additional 2,025 shares during the last quarter. Wetherby Asset Management Inc. raised its position in Cigna Corporation by 3.5% in the first quarter. Wetherby Asset Management Inc. now owns 4,159 shares of the health services provider’s stock valued at $609,000 after buying an additional 140 shares during the last quarter. Finally, Pennant Capital Management LLC purchased a new position in Cigna Corporation during the first quarter valued at $47,243,000. Hedge funds and other institutional investors own 87.61% of the company’s stock.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Insider Buying and Selling by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.